Dossier
Chinese drug
Coverage of Chinese drug in the Nexus archive.
- Chinese drug reduces lung cancer death risk by 34% in trial
A Chinese lung cancer drug reduced the risk of death by 34% in a late-stage trial, extending survival by four months when combined with chemotherapy for squamous non-small-cell lung cancer. The results highlight China's growing pharmaceutical innovation, alongside global advancements like Eli Lilly's obesity drug and a pancreatic cancer treatment.